units
BMS3021
Faculty of Medicine, Nursing and Health Sciences
This unit entry is for students who completed this unit in 2013 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.
To find units available for enrolment in the current year, you must make sure you use the indexes and browse unit tool in the current edition of the Handbook.
Level | Undergraduate |
Faculty | Faculty of Medicine, Nursing and Health Sciences |
Organisational Unit | School of Biomedical Sciences |
Offered | Clayton First semester 2013 (Day) |
Coordinator(s) | Dr Melanie Pritchard (Biochemistry and Molecular Biology) |
This unit will provide an introduction into the molecular mechanisms that mediate human diseases and the specific biotechnologies used to facilitate diagnosis and treatment. The disease mechanisms mediated by genetic disorders resulting in abnormalities in protein folding, protein trafficking and gain or loss of protein function will be presented. State of the art developments in molecular medicine including transgenic models of human disease, gene therapy, and recent developments in transplantation will be highlighted. Specific biotechnologies to be discussed include structure-based drug design, production of recombinant proteins, vaccine technology and research commercialization.
Mid semester examination (50 minutes): 10%
Final Examination (3 hours): 54%
Small group activity modules: 36%
3 lectures per week and 3 hours small group activities per week
Must be enrolled in course code 2230, 3356, 3527, 3528, 3879, 3975, 3976, 4417